• Exchange: Stuttgart
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Active Biotech AB

+ Add to Watchlist


2.127 EUR 0.171 8.74%

As of 13:20:25 ET on 01/27/2015.

Snapshot for Active Biotech AB (BTPC)

Open: 2.014 Day's Range: 1.957 - 2.127 Volume: 450
Previous Close: 1.956 52wk Range: 1.584 - 4.346 1-Yr Rtn: -49.65%

Stock Chart for BTPC

No chart data available.
  • BTPC:GR 2.127
  • 1D
  • 1M
  • 1Y
Interactive BTPC Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BTPC

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (SEK) (ttm) -
Est. EPS (SEK) (12/2014) -2.9850
Est. PEG Ratio -
Market Cap (M EUR) 191.23
Shares Outstanding (M) 89.91
30 Day Average Volume 220
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (SEK) -
Dividend Ex-Date 02/15/2001
5 Year Dividend Growth -
Next Earnings Announcement 02/11/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BTPC

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for BTPC

Active Biotech AB is a biotechnology company. The Company focuses on research and development of pharmaceuticals and vaccines. Active Biotech does research based on knowledge of the autoimmune/inflammatory diseases and cancer. The Company is developing products designed to treat a variety of diseases including multiple sclerosis, lung, renal, and pancreatic cancer.

Mats ArnhogNon-Executive ChairmanTomas LeandersonPresident/CEO
Hans KolamChief Financial OfficerHelen TuvessonChief Scientific Officer
More Company Profile & Key Executives for BTPC

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil